Not logged inPNKP safeguards stalled replication forks from nuclease-dependent degradation stress
Mashayekhi, Fatemeh; Ganje, Cassandra; Caron, Marie-Christine; Heyza, Joshua R.; Gao, Yuandi; Zeinali, Elham; Fanta, Mesfin; Li, Lei; Ali, Jana; Mersaoui, Sofiane Yacine; Schmidt, Jens C.; Godbout, Roseline; Masson, Jean-Yves; Weinfeld, Michael; Ismail, Ismail Hassan .png)
Share.png)
SaveShare Save Share Save Share Save ATR inhibition overcomes platinum tolerance associated with ERCC1-and p53-deficiency by inducing replication catastropheHeyza, Joshua R.; Ekinci, Elmira; Lindquist, Jacob; Lei, Wen; Yunker, Christopher; Vinothkumar, Vilvanathan; Rowbotham, Rachelle; Polin, Lisa; Snider, Natalie G.; Van Buren, Eric; Watza, Donovan; Back, Jessica B.; Chen, Wei; Mamdani, Hirva; Schwartz, Ann G.; Turchi, John J.; Bepler, Gerold; Patrick, Steve M. Share Save In Vivo Targeting Replication Protein A for Cancer TherapyVanderVere-Carozza, Pamela S.; Gavande, Navnath S.; Jalal, Shadia I.; Pollok, Karen E.; Ekinci, Elmira; Heyza, Joshua; Patrick, Steve M.; Masters, Andi; Turchi, John J.; Pawelczak, Katherine S. Share Save The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53Hu, Chen; Zhang, Mu; Moses, Niko; Hu, Cong-li; Polin, Lisa; Chen, Wei; Jang, Hyejeong; Heyza, Joshua; Malysa, Agnes; Caruso, Joseph A.; Xiang, Shengyan; Patrick, Steve; Stemmer, Paul; Lou, Zhenkun; Bai, Wenlong; Wang, Chuangui; Bepler, Gerold; Xiaohong Mary Zhang Share Save Share Save Share Save Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer CellsHeyza, Joshua R.; Arora, Sanjeevani; Zhang, Hao; Conner, Kayla L.; Lei, Wen; Floyd, Ashley M.; Deshmukh, Rahul R.; Sarver, Jeffrey; Trabbic, Christopher J.; Erhardt, Paul; Chan, Tak-Hang; Dou, Q. Ping; Patrick, Steve M. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
